Follow
Salah Daghlas
Salah Daghlas
Medical Student, University of Missouri
Verified email at health.missouri.edu
Title
Cited by
Cited by
Year
Skeletal response to soluble activin receptor type IIB in mouse models of osteogenesis imperfecta
Y Jeong, SA Daghlas, Y Xie, MA Hulbert, FM Pfeiffer, MR Dallas, ...
Journal of Bone and Mineral Research 33 (10), 1760-1772, 2018
312018
Soluble activin receptor type IIB decoy receptor differentially impacts murine osteogenesis imperfecta muscle function
Y Jeong, SA Daghlas, AS Kahveci, D Salamango, BA Gentry, M Brown, ...
Muscle & nerve 57 (2), 294-304, 2018
252018
Biochemistry, glycogen
SA Daghlas, SS Mohiuddin
142019
Relative effects of forced vital capacity and ALSFRS‐R on survival in ALS
SA Daghlas, R Govindarajan, ...
Muscle & Nerve 64 (3), 346-351, 2021
112021
Decreasing maternal myostatin programs adult offspring bone strength in a mouse model of osteogenesis imperfecta
AK Oestreich, WM Kamp, MG McCray, SM Carleton, N Karasseva, ...
Proceedings of the National Academy of Sciences 113 (47), 13522-13527, 2016
92016
Primary pulmonary chondrosarcoma: a case report and literature review
JT Yasin, SA Daghlas, A Hamid, AH Gaballah
Journal of Clinical Imaging Science 10, 2020
62020
RETROSPECTIVE ANALYSIS OF MYASTHENIA GRAVIS INPATIENT EXACERBATIONS AT A SINGLE MYASTHENIA GRAVIS FOUNDATION OF AMERICA/UNIVERSITY SETTING DURING 2010-2019
T Ramsaroop, R Govindarajan, S Daghlas
MUSCLE & NERVE 64, S11-S11, 2021
2021
From mouse-to patient-relevant models: Using CRISPR activation to upregulate a compensatory disease-modifying gene in LAMA2-CMD
D Kemaladewi, A Arockiaraj, JQ Cheng-Zhang, S Daghlas, C Kim
NEUROMUSCULAR DISORDERS 30, S167-S167, 2020
2020
LATE BREAKING NEWS E-POSTER PRESENTATION: LBP 1 From mouse-to patient-relevant models: Using CRISPR activation to upregulate a compensatory disease-modifying gene in LAMA2-CMD
D Kemaladewi, A Arockiaraj, JQ Cheng-Zhang, S Daghlas, C Kim
Neuromuscular Disorders 30, S167, 2020
2020
The effect of congenic myostatin inhibition on a mouse model of osteogenesis imperfecta (OI) type I/IV
AM Aguillard, VL Gremminger, SA Daghlas, Y Jeong, KL Lenz, CL Phillips
The FASEB Journal 32, lb578-lb578, 2018
2018
The Musculoskeletal Effects of Soluble Activin Receptor Type IIB (sActRIIB-mFc) in the G610C Osteogenesis Imperfecta Mouse Model.
Y Jeong, S Daghlas, M Brown, F Pfeiffer, Y Xie, M Dallas, RS Pearsall, ...
JOURNAL OF BONE AND MINERAL RESEARCH 32, S33-S33, 2017
2017
The system can't perform the operation now. Try again later.
Articles 1–11